Case: 24-1181 Document: 39 Page: 1 Filed: 07/10/2025

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ SHILPA PHARMA, INC., Appellant v. NOVARTIS PHARMACEUTICALS CORPORATION, Appellee ______________________ 2024-1181 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2022- 00886. ______________________ JUDGMENT ______________________ MARK BOLAND, Sughrue Mion, PLLC, Washington, DC, argued for appellant. Also represented by MICHAEL R. DZWONCZYK, RAJA SALIBA.

WILLIAM M. JAY, Goodwin Procter LLP, Washington, DC, argued for appellee. Also represented by ELIZABETH A.

KIERNAN, Gibson, Dunn & Crutcher LLP, Dallas, TX; JANE M. LOVE, ROBERT TRENCHARD, New York, NY. ______________________ Case: 24-1181 Document: 39 Page: 2 Filed: 07/10/2025

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (MOORE, Chief Judge, STOLL, Circuit Judge, and BUMB, Chief District Judge1).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

July 10, 2025 Date

Honorable Renée Marie Bumb, Chief Judge, United States District Court for the District of New Jersey, sitting by designation.